Health ❯ Healthcare

Medications

Weight Loss Weight Loss Drugs Side Effects GLP-1 Drugs Weight Management GLP-1 Agonists Diabetes GLP-1 Proton Pump Inhibitors Weight Loss Medications

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share

Lower-cost semaglutide generics are winning buyers in a price-sensitive market.

Amazon Pharmacy Launches Same-Day Delivery for Lilly’s Foundayo Weight-Loss Pill

Mexico Renews Warning as Counterfeit GLP-1 Weight-Loss Drugs Spread Worldwide

FDA Clears Eli Lilly’s Foundayo Oral GLP-1 for Weight Loss, With U.S. Launch Set for April 6

GLP-1 Drugs Linked to Lower Addiction Risk and Harm in Large VA Study

Heart Risks Rebound After GLP-1 Breaks, New Data Show Continuous Use Is Safest

Analyses Find Limited Savings as TrumpRx Reaches 54 Drugs

India Braces for 50+ Semaglutide Generics as Patent Expires Friday

UK Health Groups Renew Warning on Ibuprofen and Other NSAIDs Over Kidney Risk

Andalusia to Fund Vyjuvek for Epidermolysis Bullosa Patients After 12-Year-Old’s EU Plea

NICE Recommends Fezolinetant for NHS Use in England to Treat Menopausal Hot Flushes and Night Sweats

UK Flags Safety Profile of GLP-1 Weight-Loss Jabs as One in 10 Report Digestive Side Effects

Most Weight Lost on GLP-1 Drugs Returns After Stopping, New Analysis Finds

FOI Reveals Two Suspected GLP‑1 Drug Deaths in Northern Ireland

Early Tree Pollen Pushes UK Hay Fever Season Forward

Cochrane Review: Daily Aspirin Fails to Prevent Colorectal Cancer and Raises Serious Bleeding Risk

Lilly’s Oral GLP-1 Orforglipron Tops Oral Semaglutide in Lancet Phase 3 Diabetes Trial

Lilly Launches FDA-Cleared Monthly Zepbound KwikPen on LillyDirect at $299 Starter Price

Anvisa Logs 65 Suspected Deaths Linked to GLP-1 Weight-Loss Injections in Brazil

GLP-1 Weight-Loss Boom Is Reshaping Diets as Experts Urge Lifestyle Support